Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer
2018 · Journal of Clinical Oncology · 2,004 citations
https://doi.org/10.1200/jco.2017.76.9901
M
Magali Svrcek
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
250
Papers
8.5K
Citations
48
h-index
97
i10-index
Magali Svrcek is an academic researcher from Centre Léon Bérard. The author has contributed to research in topics: Genetic factors in colorectal cancer & Pancreatic and Hepatic Oncology Research & Colorectal Cancer Treatments and Studies. The author has an h-index of 48, co-authored 213 publications.
ORCID: 0000-0001-9023-5791Papers by this author
worksERBB2 gene as a potential therapeutic target in small bowel adenocarcinoma
2014 · European Journal of Cancer · 102 citations
https://doi.org/10.1016/j.ejca.2014.04.007
A transcriptomic signature to predict adjuvant gemcitabine sensitivity in pancreatic adenocarcinoma
2020 · Annals of Oncology · 79 citations
https://doi.org/10.1016/j.annonc.2020.10.601
Pacpaint: a histology-based deep learning model uncovers the extensive intratumor molecular heterogeneity of pancreatic adenocarcinoma
2023 · Nature Communications · 58 citations
https://doi.org/10.1038/s41467-023-39026-y
Tumour-infiltrating CD68+ and CD57+ cells predict patient outcome in stage II–III colorectal cancer
2013 · British Journal of Cancer · 47 citations
https://doi.org/10.1038/bjc.2013.362
ECCO Topical Review on Clinicopathological Spectrum and Differential Diagnosis of Inflammatory Bowel Disease
2021 · Journal of Crohn s and Colitis · 45 citations
https://doi.org/10.1093/ecco-jcc/jjab141
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat